新藥物遞輸系統的全球市場:2022~2026年
市場調查報告書
商品編碼
1063244

新藥物遞輸系統的全球市場:2022~2026年

Global New Drug Delivery Systems Market 2022-2026

出版日期: | 出版商: TechNavio | 英文 120 Pages | 訂單完成後即時交付

價格
簡介目錄

全球新藥物遞輸系統的市場規模在2022年~2026年間預計將成長到772億9,000萬美元,在預測期間內的年複合成長率預計將為6.08%。

市場成長的主要因素有慢性疾病的盛行率上升,生物製劑市場成長,醫療系統的數位化。

本報告提供全球新藥物遞輸系統市場相關調查分析,提供市場形勢,市場規模,波特的五力分析,各給藥途徑市場區隔,客戶·地區形勢,業者情勢,供應商分析等資訊。

目錄

摘要整理

市場概要

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 市場規模:2021年
  • 市場預測:預測(2021~2026年)

波特的五力分析

  • 五力的摘要
  • 買方議價能力
  • 供給企業談判力
  • 新加入廠商業者的威脅
  • 替代品的威脅
  • 對競爭威脅
  • 市場情況

市場區隔:各給藥途徑

  • 市場區隔
  • 比較:各給藥途徑
  • 口服藥物遞輸系統-市場規模與預測(2021~2026年)
  • 注射用藥物遞輸系統-市場規模與預測(2021~2026年)
  • 肺的藥物遞輸系統-市場規模與預測(2021~2026年)
  • 經皮吸收型藥物遞輸系統-市場規模與預測(2021~2026年)
  • 其他-市場規模與預測(2021~2026年)
  • 市場機會:各給藥途徑

客戶形勢

地區形勢

  • 地區市場區隔
  • 地區比較
  • 北美-市場規模與預測(2021~2026年)
  • 歐洲-市場規模與預測(2021~2026年)
  • 亞洲-市場規模與預測(2021~2026年)
  • 其他地區(ROW)-市場規模與預測(2021~2026年)
  • 美國-市場規模與預測(2021~2026年)
  • 德國-市場規模與預測(2021~2026年)
  • 英國-市場規模與預測(2021~2026年)
  • 中國-市場規模與預測(2021~2026年)
  • 日本-市場規模與預測(2021~2026年)
  • 市場機會:各地區形勢

促進因素,課題,及趨勢

  • 市場促進因素
  • 市場課題
  • 推動因素與課題的影響
  • 市場趨勢

業者情勢

  • 概要
  • 業者情勢
  • 創新的形勢
  • 產業的風險

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • F. Hoffmann-La Roche Ltd.
  • Gerresheimer AG
  • Kindeva Drug Delivery L.P.
  • Medtronic Plc
  • Nemera
  • Pfizer Inc.
  • West Pharmaceutical Services Inc.
  • Ypsomed Holding AG

附錄

簡介目錄
Product Code: IRTNTR72151

Technavio has been monitoring the new drug delivery systems market and it is poised to grow by $ 77.29 bn during 2022-2026, progressing at a CAGR of 6.08% during the forecast period. Our report on the new drug delivery systems market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, growth in the biologics market, and digitalization in the healthcare system. In addition, the rising prevalence of chronic diseases is anticipated to boost the growth of the market as well.

The new drug delivery systems market analysis includes the route of administration segment and geographic landscape.

Technavio's new drug delivery systems market is segmented as below:

By Route of Administration

  • Oral drug delivery systems
  • Injectable drug delivery systems
  • Pulmonary drug delivery systems
  • Transdermal drug delivery systems
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the rising prevalence of chronic diseases as one of the prime reasons driving the new drug delivery systems market growth during the next few years. Also, growth in the biologics market and digitalization in the healthcare system will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on new drug delivery systems market covers the following areas:

  • New drug delivery systems market sizing
  • New drug delivery systems market forecast
  • New drug delivery systems market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading new drug delivery systems market vendors that include Abbott Laboratories, Amgen Inc., AstraZeneca Plc, Baxter International Inc., Becton Dickinson and Co., Boehringer Ingelheim International GmbH, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Gerresheimer AG, Gilead Sciences Inc., Kindeva Drug Delivery L.P., Medtronic Plc, Merck KGaA, Nemera, Pfizer Inc., Sanofi SA, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services Inc., Ypsomed Holding AG, and Antares Pharma Inc. Also, the new drug delivery systems market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration

  • 5.1 Market segments
  • Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
  • 5.2 Comparison by Route of Administration
  • Exhibit 26: Chart on Comparison by Route of Administration
  • Exhibit 27: Data Table on Comparison by Route of Administration
  • 5.3 Oral Drug Delivery Systems - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Oral Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 29: Data Table on Oral Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 30: Chart on Oral Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Oral Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • 5.4 Injectable Drug Delivery Systems - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Injectable Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 33: Data Table on Injectable Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 34: Chart on Injectable Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Injectable Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • 5.5 Pulmonary Drug Delivery Systems - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Pulmonary Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 37: Data Table on Pulmonary Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 38: Chart on Pulmonary Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Pulmonary Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • 5.6 Transdermal Drug Delivery Systems - Market size and forecast 2021-2026
  • Exhibit 40: Chart on Transdermal Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 41: Data Table on Transdermal Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 42: Chart on Transdermal Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibit 43: Data Table on Transdermal Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • 5.7 Others - Market size and forecast 2021-2026
  • Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.8 Market opportunity by Route of Administration
  • Exhibit 48: Market opportunity by Route of Administration ($ billion)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 52: Chart on Geographic comparison
  • Exhibit 53: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 China - Market size and forecast 2021-2026
  • Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.11 Japan - Market size and forecast 2021-2026
  • Exhibit 86: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 87: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 88: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 90: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 93: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 94: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 95: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 96: Matrix on vendor position and classification
  • 10.3 Baxter International Inc.
  • Exhibit 97: Baxter International Inc. - Overview
  • Exhibit 98: Baxter International Inc. - Business segments
  • Exhibit 99: Baxter International Inc. - Key offerings
  • Exhibit 100: Baxter International Inc. - Segment focus
  • 10.4 Becton Dickinson and Co.
  • Exhibit 101: Becton Dickinson and Co. - Overview
  • Exhibit 102: Becton Dickinson and Co. - Business segments
  • Exhibit 103: Becton Dickinson and Co. - Key offerings
  • Exhibit 104: Becton Dickinson and Co. - Segment focus
  • 10.5 F. Hoffmann-La Roche Ltd.
  • Exhibit 105: F. Hoffmann-La Roche Ltd. - Overview
  • Exhibit 106: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibit 107: F. Hoffmann-La Roche Ltd. - Key news
  • Exhibit 108: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibit 109: F. Hoffmann-La Roche Ltd. - Segment focus
  • 10.6 Gerresheimer AG
  • Exhibit 110: Gerresheimer AG - Overview
  • Exhibit 111: Gerresheimer AG - Business segments
  • Exhibit 112: Gerresheimer AG - Key offerings
  • Exhibit 113: Gerresheimer AG - Segment focus
  • 10.7 Kindeva Drug Delivery L.P.
  • Exhibit 114: Kindeva Drug Delivery L.P. - Overview
  • Exhibit 115: Kindeva Drug Delivery L.P. - Product / Service
  • Exhibit 116: Kindeva Drug Delivery L.P. - Key news
  • Exhibit 117: Kindeva Drug Delivery L.P. - Key offerings
  • 10.8 Medtronic Plc
  • Exhibit 118: Medtronic Plc - Overview
  • Exhibit 119: Medtronic Plc - Business segments
  • Exhibit 120: Medtronic Plc - Key offerings
  • Exhibit 121: Medtronic Plc - Segment focus
  • 10.9 Nemera
  • Exhibit 122: Nemera - Overview
  • Exhibit 123: Nemera - Product / Service
  • Exhibit 124: Nemera - Key news
  • Exhibit 125: Nemera - Key offerings
  • 10.10 Pfizer Inc.
  • Exhibit 126: Pfizer Inc. - Overview
  • Exhibit 127: Pfizer Inc. - Business segments
  • Exhibit 128: Pfizer Inc. - Key news
  • Exhibit 129: Pfizer Inc. - Key offerings
  • Exhibit 130: Pfizer Inc. - Segment focus
  • 10.11 West Pharmaceutical Services Inc.
  • Exhibit 131: West Pharmaceutical Services Inc. - Overview
  • Exhibit 132: West Pharmaceutical Services Inc. - Business segments
  • Exhibit 133: West Pharmaceutical Services Inc. - Key offerings
  • Exhibit 134: West Pharmaceutical Services Inc. - Segment focus
  • 10.12 Ypsomed Holding AG
  • Exhibit 135: Ypsomed Holding AG - Overview
  • Exhibit 136: Ypsomed Holding AG - Business segments
  • Exhibit 137: Ypsomed Holding AG - Key offerings
  • Exhibit 138: Ypsomed Holding AG - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 139: Inclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 140: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 141: Research methodology
  • Exhibit 142: Validation techniques employed for market sizing
  • Exhibit 143: Information sources
  • 11.5 List of abbreviations
  • Exhibit 144: List of abbreviations

Exhibits

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Route of Administration
  • Exhibits27: Data Table on Comparison by Route of Administration
  • Exhibits28: Chart on Oral Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibits29: Data Table on Oral Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibits30: Chart on Oral Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Oral Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Injectable Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibits33: Data Table on Injectable Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibits34: Chart on Injectable Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Injectable Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Pulmonary Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibits37: Data Table on Pulmonary Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibits38: Chart on Pulmonary Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Pulmonary Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Chart on Transdermal Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibits41: Data Table on Transdermal Drug Delivery Systems - Market size and forecast 2021-2026 ($ billion)
  • Exhibits42: Chart on Transdermal Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibits43: Data Table on Transdermal Drug Delivery Systems - Year-over-year growth 2021-2026 (%)
  • Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits48: Market opportunity by Route of Administration ($ billion)
  • Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits52: Chart on Geographic comparison
  • Exhibits53: Data Table on Geographic comparison
  • Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ billion)
  • Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ billion)
  • Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibits87: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibits88: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits89: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits90: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits91: Impact of drivers and challenges in 2021 and 2026
  • Exhibits92: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits93: Overview on factors of disruption
  • Exhibits94: Impact of key risks on business
  • Exhibits95: Vendors covered
  • Exhibits96: Matrix on vendor position and classification
  • Exhibits97: Baxter International Inc. - Overview
  • Exhibits98: Baxter International Inc. - Business segments
  • Exhibits99: Baxter International Inc. - Key offerings
  • Exhibits100: Baxter International Inc. - Segment focus
  • Exhibits101: Becton Dickinson and Co. - Overview
  • Exhibits102: Becton Dickinson and Co. - Business segments
  • Exhibits103: Becton Dickinson and Co. - Key offerings
  • Exhibits104: Becton Dickinson and Co. - Segment focus
  • Exhibits105: F. Hoffmann-La Roche Ltd. - Overview
  • Exhibits106: F. Hoffmann-La Roche Ltd. - Business segments
  • Exhibits107: F. Hoffmann-La Roche Ltd. - Key news
  • Exhibits108: F. Hoffmann-La Roche Ltd. - Key offerings
  • Exhibits109: F. Hoffmann-La Roche Ltd. - Segment focus
  • Exhibits110: Gerresheimer AG - Overview
  • Exhibits111: Gerresheimer AG - Business segments
  • Exhibits112: Gerresheimer AG - Key offerings
  • Exhibits113: Gerresheimer AG - Segment focus
  • Exhibits114: Kindeva Drug Delivery L.P. - Overview
  • Exhibits115: Kindeva Drug Delivery L.P. - Product / Service
  • Exhibits116: Kindeva Drug Delivery L.P. - Key news
  • Exhibits117: Kindeva Drug Delivery L.P. - Key offerings
  • Exhibits118: Medtronic Plc - Overview
  • Exhibits119: Medtronic Plc - Business segments
  • Exhibits120: Medtronic Plc - Key offerings
  • Exhibits121: Medtronic Plc - Segment focus
  • Exhibits122: Nemera - Overview
  • Exhibits123: Nemera - Product / Service
  • Exhibits124: Nemera - Key news
  • Exhibits125: Nemera - Key offerings
  • Exhibits126: Pfizer Inc. - Overview
  • Exhibits127: Pfizer Inc. - Business segments
  • Exhibits128: Pfizer Inc. - Key news
  • Exhibits129: Pfizer Inc. - Key offerings
  • Exhibits130: Pfizer Inc. - Segment focus
  • Exhibits131: West Pharmaceutical Services Inc. - Overview
  • Exhibits132: West Pharmaceutical Services Inc. - Business segments
  • Exhibits133: West Pharmaceutical Services Inc. - Key offerings
  • Exhibits134: West Pharmaceutical Services Inc. - Segment focus
  • Exhibits135: Ypsomed Holding AG - Overview
  • Exhibits136: Ypsomed Holding AG - Business segments
  • Exhibits137: Ypsomed Holding AG - Key offerings
  • Exhibits138: Ypsomed Holding AG - Segment focus
  • Exhibits139: Inclusions checklist
  • Exhibits140: Currency conversion rates for US$
  • Exhibits141: Research methodology
  • Exhibits142: Validation techniques employed for market sizing
  • Exhibits143: Information sources
  • Exhibits144: List of abbreviations